Evidence map›Paper›PMID 28665124›Full record

ArticleJournal of the American Chemical Society2017

Enantioselective Rhodium(III)-Catalyzed Markovnikov Hydroboration of Unactivated Terminal Alkenes.

James R Smith, Beatrice S L Collins, Matthew J Hesse, Mark A Graham, Eddie L Myers, Varinder K Aggarwal

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Amide directed iridium C(spTetrahedron · 2022
    Article
  11. Article
  12. Hydroboration of Terminal Alkenes andAngewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2021
    Article
  13. Article
  14. Article
  15. Chemical science · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

James R SmithSchool of Chemistry, University of Bristol , Cantock's Close, Bristol BS8 1TS, United Kingdom.
Beatrice S L CollinsSchool of Chemistry, University of Bristol , Cantock's Close, Bristol BS8 1TS, United Kingdom.
Matthew J HesseSchool of Chemistry, University of Bristol , Cantock's Close, Bristol BS8 1TS, United Kingdom.
Mark A GrahamPharmaceutical Technology and Development, AstraZeneca , Silk Road Business Park, Charter Way, Macclesfield SK10 2NA, United Kingdom.
Eddie L MyersSchool of Chemistry, University of Bristol , Cantock's Close, Bristol BS8 1TS, United Kingdom.ORCID 0000-0001-7742-4934
Varinder K AggarwalSchool of Chemistry, University of Bristol , Cantock's Close, Bristol BS8 1TS, United Kingdom.ORCID 0000-0003-0344-6430

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the first enantioselective Rh-catalyzed Markovnikov hydroboration of unactivated terminal alkenes. Using a novel sp

Identifiers

PMID28665124
PMCPMC5515510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.